Orgenesis Inc (ORGS): Price-to-Revenue Coefficient

Brandmark of Orgenesis Inc (ORGS)

Orgenesis Inc. (ORGS) is developing the POCare network to optimize cell production costs through CDMO contracts. Historical P/S dynamics demonstrate the market valuation of revenue, where the 15.10 level reflects the current multiple. The strategy of deploying mobile laboratories within clinics accelerates personalized treatment, although high debt and platform scaling challenges are currently weakening the company's competitive advantages.

Orgenesis (ORGS): Price-to-Revenue Ratio from 07/04/2022 to 10/26/2024

Analytical breakdowns for Orgenesis Corp (ORGS)

- current quotes and average value forecast:
Market Price orgenesis.com|ORGS - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Orgenesis Corp|ORGS - Enterprise Value
- company book value details:
Net Assets per Share Orgenesis|ORGS - Company Book Value|Market Capitalization to Book Value orgenesis.com|ORGS - Cumulative Company Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio Orgenesis Inc.|ORGS - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Orgenesis Corporation|ORGS - Company Debts|Debt to Book Value Ratio Orgenesis Corp|ORGS - Company Long-Term Debts|Company Current Liabilities Orgenesis|Interim Coverage Ratio orgenesis.com
- net income and valuation ratios data:
ORGS - Company Net Income|Expected Net Profit Orgenesis Inc.|ORGS - Price to Earnings Ratio|Future Price to Earnings Multiple Orgenesis Inc|ORGS - PEG Multiple|Enterprise Value to EBITDA Multiple Orgenesis Corp|ORGS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Orgenesis|ORGS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months orgenesis.com|ORGS - Net earnings per share growth this year|Projected earnings per share increase next year Orgenesis Inc.
- total revenue and sales volume data:
ORGS - Company Sales|Company Future Revenue orgenesis.com|ORGS - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Orgenesis Corp
Fundamental company analysis:orgenesis.com (ORGS)
Finished products of Orgenesis Inc.

The P/S multiple compares market capitalization to annual revenue, determining the extent to which investors are overpaying for every dollar of the business's gross income. By analyzing the price-to-sales multiple history, one can assess how closely market expectations for the implementation of decentralized cell therapy in clinics and institutes align with the actual monetization rates of Orgenesis Inc. technological solutions.

Competing companies

VEEV - Price to Sales|Price-to-Revenue Ratio Doximity DOCS|Price-to-Revenue Coefficient HealthEquity Inc (HQY)|Waystar Inc. - P/S Multiple|Price-to-Revenue Coefficient CorVel Corp. CRVL|Privia Health Group (PRVA) - Price-to-Revenue Ratio|HURN - Price-to-Revenue Coefficient|Market Cap to Revenue CERT|OMCL: Market Capitalization-to-Revenue Ratio|P/S Multiple GDRX|Price-to-Revenue Coefficient Schrodinger Corp|Price-to-Revenue Ratio Phreesia, Inc. PHR|OMDA: Market Cap to Revenue Ratio|Evolent Health - P/S Multiple|HealthStream Inc (HSTM) - Market Cap to Revenue|DH (Definitive Healthcare Inc.) - Market Cap to Revenue|CCSI - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Agilon Health|Price to Sales absci.com ABSI|Price-to-Revenue Ratio So-Young International Inc. (SY)|NRC (NRC Health) - Market Capitalization-to-Revenue Ratio|P/S Multiple SPOK (Spok Corp)|Price-to-Revenue Multiple OptimizeRx Inc.|TBRG - Price-to-Revenue Ratio|Price-to-Revenue Coefficient simulations-plus.com SLP|SOPH: P/S Multiple|HCAT - Price-to-Revenue Coefficient|Market Cap to Revenue CCLD|RSSS (Research Solutions Inc.) - Market Cap to Sales Volume|Market Cap to Revenue DLHC (DLH Holdings Corp.)|ONMD (onemednet.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Scienture SCNX|HCTI - Market Cap to Revenue|iSpecimen Corp - P/S Multiple|Price to Sales Bullfrog AI Holdings|WORX: P/S Multiple|Market Cap to Revenue Ratio MSPR|Price-to-Revenue Ratio iCoreConnect, Inc.|Price to Sales TRxADE HEALTH Inc MEDS|Price-to-Revenue Ratio R1 RCM Inc. (RCM)|SHCR (Sharecare Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple STRM (Streamline Health Solutions)|Price-to-Revenue Multiple syrahealth.com|ApolloMed - P/S Multiple|Price to Sales Model N Inc|NextGen (NXGN) - Price-to-Revenue Ratio